Status: Recruiting
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
The Purpose of this study is to evaluate the efficacy and safety of intravenous HRS9432 in patients with candidemia and/or invasive candidiasis
Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Nov 18, 2024Locations: 1
Eligibility criteria
Males or females ≥18 years; [+4]
Any of the following forms of IC: including osteomyelitis, endocarditis or myoca... [+11]